BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Franco Machado J, Silva RD, Melo R, G Correia JD. Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and Theranostics. Molecules 2018;24:E49. [PMID: 30583594 DOI: 10.3390/molecules24010049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Pirzada RH, Javaid N, Choi S. The Roles of the NLRP3 Inflammasome in Neurodegenerative and Metabolic Diseases and in Relevant Advanced Therapeutic Interventions. Genes (Basel) 2020;11:E131. [PMID: 32012695 DOI: 10.3390/genes11020131] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
2 Chan HS, Shan H, Dahoun T, Vogel H, Yuan S. Advancing Drug Discovery via Artificial Intelligence. Trends in Pharmacological Sciences 2019;40:592-604. [DOI: 10.1016/j.tips.2019.06.004] [Cited by in Crossref: 82] [Cited by in F6Publishing: 59] [Article Influence: 27.3] [Reference Citation Analysis]
3 Xu X, Zhang M, Xu F, Jiang S. Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities. Mol Cancer. 2020;19:165. [PMID: 33234169 DOI: 10.1186/s12943-020-01276-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
4 Wong XK, Yeong KY. A Patent Review on the Current Developments of Benzoxazoles in Drug Discovery. ChemMedChem 2021. [PMID: 34289258 DOI: 10.1002/cmdc.202100370] [Reference Citation Analysis]
5 Childs MD, Luyt LG. A Decade's Progress in the Development of Molecular Imaging Agents Targeting the Growth Hormone Secretagogue Receptor. Mol Imaging 2020;19:1536012120952623. [PMID: 33104445 DOI: 10.1177/1536012120952623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bergmann R, Chollet C, Els-Heindl S, Ullrich M, Berndt N, Pietzsch J, Máthé D, Bachmann M, Beck-Sickinger AG. Development of a ghrelin receptor inverse agonist for positron emission tomography. Oncotarget 2021;12:450-74. [PMID: 33747360 DOI: 10.18632/oncotarget.27895] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Machado JF, Correia JDG, Morais TS. Emerging Molecular Receptors for the Specific-Target Delivery of Ruthenium and Gold Complexes into Cancer Cells. Molecules 2021;26:3153. [PMID: 34070457 DOI: 10.3390/molecules26113153] [Reference Citation Analysis]